Immune Response after mRNA COVID-19 Vaccination in Lung Transplant Recipients: A 6-Month Follow-Up.
Selma TobudicAlberto BenazzoMaximilian KoblischkeLisa SchneiderStephan BlümlFlorian WinklerHannah SchmidtStefan VorlenHelmuth HaslacherThomas PerkmannHeinz BurgmannPeter JakschJudith H AberleStefan WinklerPublished in: Vaccines (2022)
The data suggest that LuTRs have reduced humoral and cellular immune responses after two doses of COVID-19 mRNA vaccination when compared to HCs. A third dose may be of substantial benefit.